Physician profile
Hawk Cambron
NPI 1144726878
$1,181.52
in general payments reported to CMS, 2019-2025
16 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $172 · 2022: $200 · 2023: $264 · 2024: $277 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.61 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $584.53 | 2021-2025 | Vraylar |
| Astrazeneca Pharmaceuticals LP | $178.47 | 2021-2025 | Breztri |
| Lilly USA, LLC | $78.93 | 2024-2025 | Zepbound, Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.61 | 2025 | Caplyta |
| Amgen INC. | $47.92 | 2022-2024 | Otezla, Repatha |
| Novo Nordisk INC | $47.06 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $44.35 | 2025 | Fanapt |
| Alkermes, INC. | $29.26 | 2023 | Aristada, Lybalvi |
| Abbott Laboratories | $21.87 | 2023 | Proclaim |
| Lundbeck LLC | $16.79 | 2025 | Rexulti |
| Dexcom, INC. | $14.99 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $14.64 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $14.05 | 2021 | |
| Pfizer INC. | $13.48 | 2021 | |
| Glaxosmithkline, LLC. | $13.45 | 2024 | Trelegy Ellipta |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.12 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hawk Cambron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.